Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2 (original) (raw)

Tumour necrosis factor and other cytokines in murine lupus

A. Theofilopoulos

Annals of the Rheumatic Diseases, 1999

View PDFchevron_right

Interleukin 2 and systemic lupus erythematosus

Mariana Diaz-zamudio

Autoimmunity Reviews, 2009

View PDFchevron_right

Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus

Stephen Rozzo

The Journal of Immunology

View PDFchevron_right

Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene

John Roths

Journal of Experimental Medicine, 1981

View PDFchevron_right

Both cloned interleukin 2 and purified interleukin 1 are required for optimal growth of purified L3T4+ and LyT 2+ lymphocytes initiated by concanavalin A

Taina Leu

Cellular Immunology, 1985

View PDFchevron_right

Suppression of immunoglobulin synthesis of systemic lupus erythematosus patients by concanavalin A-activated normal human spleen cell supernatants

Randall Krakauer

Clinical Immunology and Immunopathology, 1980

View PDFchevron_right

Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes

A. Theofilopoulos

Journal of Experimental Medicine, 1979

View PDFchevron_right

Defective CD2 pathway T cell activation in systemic lupus erythematosus

joel depper

Arthritis and Rheumatism, 1991

View PDFchevron_right

Effect of Injection of Anti-CD4 and Anti-CD8 Monoclonal Antibodies on the Development of Experimental Systemic Lupus Erythematosus in Mice

Edna Mozes

Cellular Immunology, 1996

View PDFchevron_right

Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus

William Stohl

Clinical immunology and immunopathology, 1992

View PDFchevron_right

Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus

Ivan Stekman, Ana Blasini

Arthritis & Rheumatism, 1991

View PDFchevron_right

Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus

James Louie

Arthritis and Rheumatism, 1978

View PDFchevron_right

Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice

Emmanuel Besa

The American journal of pathology, 1991

View PDFchevron_right

Effect of anti-T cell auto antibodies from systemic lupus erythematosus sera upon T lymphocyte functions

Thomas Kresina

Arthritis & Rheumatism, 1986

View PDFchevron_right

Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: Relationship to clinical activity

Delbert Wigfall

Clinical Immunology and Immunopathology, 1988

View PDFchevron_right

Induction of experimental systemic lupus erythematosus (SLE) in mice with severe combined immunodeficiency (SCID)

Edna Mozes

Clinical & Experimental Immunology, 2008

View PDFchevron_right

Effect of Aging on Cytokine Production in Normal and Experimental Systemic Lupus Erythematosus-Afflicted Mice

Molly Dayan

Experimental Gerontology, 2000

View PDFchevron_right

Conserved anti-proliferative effect and poor inhibition of TNFα secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus

JESUS DAVID D RODRIGUEZ GOMEZ

Clinical Immunology, 2009

View PDFchevron_right

Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB × NZW)F1 hybrid

marta riquelme

Clinical Immunology and Immunopathology, 1992

View PDFchevron_right

Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus

Chikao Morimoto

Journal of Clinical Investigation, 1980

View PDFchevron_right

T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells

Chandra Mohan

Journal of Clinical Investigation, 2005

View PDFchevron_right

The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus

Brian Flanagan

Pediatric Rheumatology, 2014

View PDFchevron_right

Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells

Mariana Linker-Israeli

Journal of Clinical Investigation, 1985

View PDFchevron_right

Differences between CD8+ T cells in lupus-prone (NZB× NZW) F1 mice and healthy (BALB/c× NZW) F1 mice may influence autoimmunity in the lupus model

George Karpouzas

European Journal of Immunology, 2004

View PDFchevron_right

Impaired cell-mediated immunity in systemic lupus erythematosus (SLE)

Alfonse Masi

The American Journal of Medicine, 1975

View PDFchevron_right

THE IMMUNOPATHOLOGY OF LUPUS ERYTHEMATOSUS. *

Edward Franklin

British Journal of Dermatology, 1960

View PDFchevron_right

Clinical and histopathological progression of lesions in lupus-prone (NZB×NZW) F1 mice

Jacques Descotes

Experimental and Toxicologic Pathology, 2004

View PDFchevron_right

Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus

Junji Yodoi

The Journal of Immunology

View PDFchevron_right